Opto Circuits' shares surge over 7% on bourses

Stocks of medical devices firm Opto Circuits India today surged over 7 per cent after the company said its US arm Cardiac Science has received US health regulator's clearance to market its new automated external defibrillator (AED) in the American market.
The stock ended the day with a gain of 7.36 per cent at Rs 21.15 per scrip on the BSE.
In intra-day trade, it jumped 14.21 per cent to Rs 22.50.
At the NSE, it gained 7.36 per cent to settle at Rs 21.15.
On the volume front, 16.20 lakh shares of the company changed hands at the BSE and over 65 lakh shares were traded at the NSE during the day.

Cardiac Science's 'Powerheart G5 AED with CRPD' has received 510(k) market clearance from the United States Food and Drug Administration (USFDA), allowing it to begin selling the product along with Powerheart G3 and G5 product line, Opto Circuits said in a statement.
The Powerheart family of AEDs is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered sudden cardiac arrest, a condition in which the heart suddenly stops beating due to ill regularities in its electrical system, Opto Circuits India said.
Meanwhile, in the broader market, the benchmark BSE Sensex ended 722.77 points down at 26,717.37.